IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children: Comparison of Dosing, Anticoagulation Quality, Efficacy, and Safety Outcomes*
Yaser Diab, Dilip S. Nath(St. Louis Children's Hospital), David Zurakowski(Boston Children's Hospital), John Berger(Children's National), Venkat Shankar(Children's National), Sara P. Rooney(Children's National), Fahad A. Alfares(Children's National), Brandon E. Ferrell(Montefiore Medical Center), Jason Corcoran(Children's National), Reginald Chounoune(Children's National), Kendal M. Endicott(Children's National), Karthik Ramakrishnan(Children's National)
Cited by 16
Related Papers
Therapeutic Hypothermia after Out-of-Hospital Cardiac Arrest in Children
|New England Journal of Medicine|2015|435
Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation
|American Journal of Respiratory and Critical Care Medicine|2017|355
Pediatric Intensive Care Outcomes
|Pediatric Critical Care Medicine|2014|333
Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill Children
|PEDIATRICS|2010|324
Autologous Chondrocyte Implantation of the Knee: Multicenter Experience and Minimum 3-Year Follow-Up
|Clinical Journal of Sport Medicine|2001|306